Organon (OGN) P/S (2021 - 2026)
Organon (OGN) P/S from May 14, 2021 to Jun 12, 2026. The TTM Organon (OGN) P/S is 0.57. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Organon (OGN)
| Year | P/S | Change |
|---|---|---|
| 2026 | 0.57 | +90.75% |
| 2025 | 0.30 | -50.01% |
| 2024 | 0.60 | +0.23% |
| 2023 | 0.60 | -46.92% |
| 2022 | 1.13 | -7.84% |
| 2021 | 1.23 | N/A |
Comparison Organon (OGN) P/S with competitors
Organon (OGN) P/S is 0.57.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 0.55 | -3.28% |
| GRFS | Grifols SA | 0.67 | +17.32% |
| AMRN | Amarin Corp | 1.44 | +151.41% |
| SCLX | Scilex Holding Company | 1.83 | +219.15% |
| SNY | Sanofi | 2.26 | +294.75% |
| PFE | Pfizer Inc | 2.31 | +303.82% |
| BMY | Bristol-Myers Squibb Company | 2.38 | +315.35% |
| BIIB | Biogen Inc | 2.96 | +416.43% |
| GSK | GSK Plc | 3.13 | +447.16% |
| MRK | Merck & Co Inc | 4.49 | +684.08% |
| AZN | Astrazeneca plc | 4.59 | +700.84% |
| AMGN | AMGEN Inc | 5.00 | +772.25% |
| NVS | Novartis AG | 5.03 | +778.18% |
| GILD | Gilead Sciences Inc | 5.24 | +814.85% |
| JNJ | Johnson & Johnson | 5.92 | +933.57% |
| ABBV | Abbvie Inc | 6.34 | +1006.89% |
| LLY | Lilly(Eli) & Company | 14.13 | +2366.94% |